Work

Scale-Up of Nanopharmaceutical Formulations: Integrating Critical Quality Attributes, Process Analytical Technology, and Regulatory Challenges into a Decision Framework

Year: 2026
Type: article
Abstract: Nanopharmaceuticals are generally successful at laboratory scale, but once production levels rise, their quality suffers, and the reasons for this are seldom explored in relation to monitoring and regulatory requirements. This critical review considers 90 peer-reviewed sources, 77 of which are published from 2020 onward, and explores the relationship between formulation composition, process conditions, particle attributes, in-process monitoring, and regulatory expectations during scale-up. The size, polydispersity, payload integrity and storage stability of lipid nanoparticles, liposomes, polymeric nanoparticles, nanoemulsions and nanocrystals respond differently to changes in mixing, shear, filtration time and freezing history. Quality-by-design studies rarely report design spaces at production scale and most process analytical technology work is focused on particle size, while encapsulation, payload integrity and lipid quality are still tested offline. Nanomedicines are regulated on a case-by-case basis in regulatory documents and no harmonized comparability pathway exists. An unvalidated framework is presented in the review linking material attributes, process parameters, quality attributes, monitoring tier and comparability evidence through a decision matrix and decision-flow diagram. The framework identifies scale sensitive, history sensitive and material sensitive attributes and assigns a monitoring and control strategy to each of them. The priority research needs are inline methods for payload integrity, scale-transferable design spaces, validated digital models and agreed comparability criteria. The proposals have to be tested in prospective real manufacturing programs.
Author: Arbaz Khan
Institution: Mandsaur University
Language: English
Subfield: Biomaterials
Open Access status: hybrid
OpenAlex ID: W7235683498
FWCI:
Cites: 84
Cited by:
Related to: 10